Evolent Health (EVH) Tops Q3 EPS by 50c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Evolent Health Announces Third Quarter 2022 Results
November 2, 2022 4:10 PM EDTWASHINGTON, Nov. 2, 2022 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a health care company that delivers proven clinical and administrative solutions to payers and providers, today announced financial results for the quarter ended September 30, 2022.
Highlights from the third quarter of 2022 announcement include:
Quarter ended September 30, 2022:
Revenue of $352.6 million, an increase of $130.1 million, or 58.5%, from the three months ended September 30, 2021.Net income attributable to common shareholders of Evolent Health, Inc. of $2.1 million resulting in a net income... More